Surveillance of COVID-19 in migrant reception centres: a call for action

Ceccarelli, Giancarlo; Lopalco, Maurizio; d’Ettorre, Gabriele; d’Ettorre, Gabriella; Ciccozzi, Massimo

doi:10.1093/jtm/taaa171

Cited by 10 publications

(16 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A potential lack of knowledge and awareness of COVID-19 among migrant groups or spread of misinformation has been reported ( Doctors of the World 2020 ). For example, in qualitative interviews conducted in a migrant reception centre in Rocca di Papa, Italy between February and July 2020, there was low awareness of the danger of the pandemic, especially among migrants from sub-Saharan Africa ( Ceccarelli et al, 2020 ). There is some evidence that traditional Chinese medicine may have been used as a means of preventing COVID-19 among Chinese immigrants in Canada ( Bodenmann et al, 2020 , Kong et al, 2020 ).…”

Section: Resultsmentioning

confidence: 99%

Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review

Hayward

Deal

Cheng

et al. 2021

Journal of Migration and Health

222

169

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review

Hayward

Deal

Cheng

et al. 2021

Journal of Migration and Health

222

169

View full text Add to dashboard Cite

“…A potential lack of knowledge and awareness of COVID-19 among migrant groups or spread of misinformation has been reported (50). For example, in qualitative interviews conducted in a migrant reception centre in Rocca di Papa, Italy between February and July 2020, there was low awareness of the danger of the pandemic, especially among migrants from sub-Saharan Africa (128). There is some evidence that traditional Chinese medicine may have been used as a means of preventing COVID-19 among Chinese immigrants in Canada (124, 129).…”

Section: Resultsmentioning

confidence: 99%

Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: a systematic review

Hayward

Deal

Cheng

et al. 2020

Preprint

View full text Add to dashboard Cite

BackgroundMigrants, including refugees, asylum seekers, labour migrants, and undocumented migrants, now constitute a considerable proportion of most high-income countries’ populations, including their skilled and unskilled workforces. Migrants may be at increased risk of COVID-19 due to their health and social circumstances, yet the extent to which they are being affected and their predisposing risk factors are not clearly understood. We did a systematic review to assess clinical outcomes of COVID-19 in migrant populations (cases, hospitalisations, deaths), indirect health and social impacts, and to determine key risk factors.MethodsWe did a systematic review following PRISMA guidelines, registered with PROSPERO (CRD42020222135). We searched databases including PubMed, Global Health, Scopus, CINAHL, and pre-print databases (medRxiv) via the WHO Global Research on COVID-19 database to Nov 18, 2020 for peer-reviewed and grey literature pertaining to migrants (defined as foreign born) and COVID-19 in 82 high-income countries. We used our international networks to source national datasets and grey literature. Data were extracted on our primary outcomes (cases, hospitalisations, deaths) and we evaluated secondary outcomes on indirect health and social impacts, and risk factors, using narrative synthesis.Results3016 data sources were screened with 158 from 15 countries included in the analysis (35 data sources for primary outcomes: cases [21], hospitalisations [4]; deaths [15]; 123 for secondary outcomes). We found that migrants are at increased risk of infection and are disproportionately represented among COVID-19 cases. Available datasets suggest a similarly disproportionate representation of migrants in reported COVID-19 deaths, as well as increased all-cause mortality in migrants in some countries in 2020. Undocumented migrants, migrant health and care workers, and migrants housed in camps and labour compounds may have been especially affected. In general, migrants have higher levels of many risk factors and vulnerabilities relevant to COVID-19, including increased exposure to SARS-CoV-2 due to high-risk occupations and overcrowded accommodation, and barriers to health care including inadequate information, language barriers, and reduced entitlement to healthcare coverage related to their immigration status.ConclusionsMigrants in high-income countries are at high risk of exposure to, and infection with, COVID-19. These data are of immediate relevance to national public health responses to the pandemic and should inform policymaking on strategies for reducing transmission of COVID-19 in this population. Robust data on testing uptake and clinical outcomes in migrants, and barriers and facilitators to COVID-19 vaccination, are urgently needed, alongside strengthening engagement with diverse migrant groups.

show abstract

“…The lung damage has initially characterized coronavirus disease 2019 (COVID‐19) disease. Later considerable amounts of patients with a multiorgan involvement, principally characterized by coagulopathy and cardiovascular disorders, were diagnosed as COVID‐19 2–13 …”

Section: Introductionmentioning

confidence: 99%

Ozone as adjuvant support in the treatment of COVID‐19: A preliminary report of probiozovid trial

Araimo

Imperiale

Tordiglione

et al. 2020

Journal of Medical Virology

Self Cite

View full text Add to dashboard Cite

The evaluation of new therapeutic resources against coronavirus disease 2019 (COVID‐19) represents a priority in clinical research considering the minimal options currently available. To evaluate the adjuvant use of systemic oxygen‐ozone administration in the early control of disease progression in patients with COVID‐19 pneumonia. PROBIOZOVID is an ongoing, interventional, randomized, prospective, and double‐arm trial enrolling patient with COVID‐19 pneumonia. From a total of 85 patients screened, 28 were recruited. Patients were randomly divided into ozone‐autohemotherapy group (14) and control group (14). The procedure consisted in a daily double‐treatment with systemic Oxygen–ozone administration for 7 days. All patients were treated with ad interim best available therapy. The primary outcome was delta in the number of patients requiring orotracheal‐intubation despite treatment. Secondary outcome was the difference of mortality between the two groups. Moreover, hematological parameters were compared before and after treatment. No differences in the characteristics between groups were observed at baseline. As a preliminary report we have observed that one patient for each group needed intubation and was transferred to ITU. No deaths were observed at 7–14 days of follow up. Thirty‐day mortality was 8.3% for ozone group and 10% for controls. Ozone therapy did not significantly influence inflammation markers, hematology profile, and lymphocyte subpopulations of patients treated. Ozone therapy had an impact on the need for the ventilatory support, although did not reach statistical significance. Finally, no adverse events related to the use of ozone‐autohemotherapy were reported. Preliminary results, although not showing statistically significant benefits of ozone on COVID‐19, did not report any toxicity.

show abstract

Surveillance of COVID-19 in migrant reception centres: a call for action

Cited by 10 publications

References 5 publications

Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review

Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review

Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: a systematic review

Ozone as adjuvant support in the treatment of COVID‐19: A preliminary report of probiozovid trial

Contact Info

Product

Resources

About